Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.64 USD | +0.59% | -1.95% | +11.74% |
04-23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
04-23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.74% | 1.39B | |
+5.02% | 109B | |
+11.01% | 105B | |
-0.38% | 22.25B | |
-12.07% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.17% | 16.85B | |
+3.64% | 13.76B | |
+35.95% | 12.46B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Transcript : Kiniksa Pharmaceuticals, Ltd., Q3 2023 Earnings Call, Oct 31, 2023